ABACUS GLOBAL MANAGEMENT, INC. INVESTIGATION: ABX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
ABACUS GLOBAL MANAGEMENT, INC. INVESTIGATION: ABX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
The law firm of Kirby McInerney LLP is investigating potential claims against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NYSE: ABX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Abacus securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
[LEARN MORE ABOUT POTENTIAL SECURITIES FRAUD CLAIMS]
What Happened?
On November 17, 2026, Abacus filed a notification of late filing on Form 12b-25 with the SEC, stating that the Company is unable to timely file its Quarterly Report on Form 10-Q for third quarter 2026. Abacus stated that the delay was “a result of its ongoing evaluation of the accounting for capital account credits provided to the limited partners of certain private funds advised by the Company starting in the second quarter of 2025, as well as the accounting associated with certain transactions between the Company and its related party funds.” The Company stated it would then “evaluate the materiality of any identified issues in the Company’s previously filed periodic reports, potentially dating back to June 30, 2025, to determine whether corrections are required. Additionally, the Company will need to perform a reassessment of its internal controls over financial reporting related to these items, which may result in a conclusion that the Company’s disclosure controls and procedures and internal control over financial reporting were not effective.” On this news, the price of Abacus shares declined by $2.00 per share, or approximately 23.1%, from $8.65 per share on November 16, 2026 to close at $6.65 on November 17, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired Abacus securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT YOUR RIGHTS AS AN INVESTOR]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261119860121/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

The 10 Best Dividend Stocks

5 Stocks to Buy After Earnings

2 5-Star Stocks to Buy at Big Discounts

Tech Stocks Suffer Worst Week Since 2020 as Anthropic Faces Day Two Decline
